|
Demographic criteria
|
|
• Age (years)
|
Median (min–max)
|
56.5 (42–75)
|
|
• Sex (Male)
|
Count (%)
|
166 (65.9%)
|
|
Pre-intervention reserve liver functions
|
|
• ALT (IU/L)
|
Median (min–max)
|
39 (18–74)
|
|
• AST (IU/L)
|
Median (min–max)
|
43 (20–81)
|
|
• s.albumin (gm/dl)
|
Median (min–max)
|
3.4 (2.7–3.9)
|
|
• s.bilirubin (mg/dl)
|
Median (min–max)
|
1.4 (0.9–1.9)
|
|
• Prothrombin concentration (%)
|
Median (min–max)
|
71 (61–89)
|
|
Pre-interventional liver volumetric values and ratios
|
|
• Liver volume (LV) (cm3)
|
Median (min–max)
|
1714 (1011–3243)
|
|
• Tumor volume (TV) (cm3)
|
Median (min–max)
|
383 (83–1269)
|
|
• Residual volume (RV) (cm3)
|
Median (min–max)
|
1336 (827–2418)
|
|
• Residual to liver volumetric ratio (RLVR)
|
Median (min–max)
|
0.7 (0.43–0.95)
|
|
Other evaluated clinical and laboratory parameters
|
|
• Spleen diameter (cm)
|
Median (min–max)
|
14 (10–20)
|
|
• s.creatinine (mg/dl)
|
Median (min–max)
|
1.1 (0.8–1.3)
|
|
• Platelets (x103/mm3)
|
Median (min–max)
|
149 (68–215)
|
|
• Child-Pugh score
|
A5
|
Count (%)
|
62 (24.6%)
|
|
A6
|
Count (%)
|
102 (40.5%)
|
|
B7
|
Count (%)
|
85 (33.7%)
|
|
B8
|
Count (%)
|
3 (1.2%)
|
|
• AFP (ng/ml)
|
Median (min–max)
|
129 (11–1245)
|
|
Post intervention measured criteria
|
|
• Time to decompensation (week)
|
Median (min–max)
|
6 (1–6)
|
|
• Hepatic decompensation
|
Decompensation
|
82, 32.5%
|
|
No decompensation
|
170, 68.5%
|
|
Total
|
252, 100%
|
